학술논문

Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.
Document Type
Journal Article
Author
Lindner, Mark D.. Department of Neuroscience Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US, mark.lindner@bms.com; Bourin, Clotilde. Department of Neuroscience Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US; Chen, Ping. Department of Neuroscience Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US; McElroy, John F.. Department of Neuroscience Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US; Leet, John E.. Department of New Leads Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US; Hogan, John B.. Department of Neuroscience Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US; Stock, David A.. Department of Biostatistics, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US; Machet, Frederic. Department of Neuroscience Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, US
Source
Experimental and Clinical Psychopharmacology, Vol 14(1), Feb, 2006. pp. 42-51.
Subject
*Amitriptyline; *Anticonvulsive Drugs; *Drug Therapy; *Pain Perception; *Side Effects (Drug); Animal Models; Cognitive Impairment; Diabetes; Drugs; Motor Processes; Nervous System Disorders; Neuropathy; Rats; Gabapentin
Language
English
ISSN
1064-1297 (Print)
1936-2293 (Electronic)